162 related articles for article (PubMed ID: 36840679)
41. Derivation of a biological limit value (BLV) for inorganic lead based on lead-induced genotoxicity in workers using the benchmark dose approach (BMD).
Duydu Y
J Trace Elem Med Biol; 2022 Jan; 69():126894. PubMed ID: 34749035
[TBL] [Abstract][Full Text] [Related]
42. Misinterpretation and misuse of exposure limits.
Hewett P
Appl Occup Environ Hyg; 2001 Feb; 16(2):251-6. PubMed ID: 11217719
[TBL] [Abstract][Full Text] [Related]
43. Identification of N-nitrosamines in treated drinking water using nanoelectrospray ionization high-field asymmetric waveform ion mobility spectrometry with quadrupole time-of-flight mass spectrometry.
Zhao YY; Liu X; Boyd JM; Qin F; Li J; Li XF
J Chromatogr Sci; 2009 Jan; 47(1):92-6. PubMed ID: 19161662
[TBL] [Abstract][Full Text] [Related]
44. Identification and quantitation of N-nitrosamines in human postmortem organs.
Cooper SF; Lemoyne C; Gauvreau D
J Anal Toxicol; 1987; 11(1):12-8. PubMed ID: 3821072
[TBL] [Abstract][Full Text] [Related]
45. Experiences from occupational exposure limits set on aerosols containing allergenic proteins.
Nielsen GD; Larsen ST; Hansen JS; Poulsen LK
Ann Occup Hyg; 2012 Oct; 56(8):888-900. PubMed ID: 22843406
[TBL] [Abstract][Full Text] [Related]
46. Cytochrome P450 2A-catalyzed metabolic activation of structurally similar carcinogenic nitrosamines: N'-nitrosonornicotine enantiomers, N-nitrosopiperidine, and N-nitrosopyrrolidine.
Wong HL; Murphy SE; Hecht SS
Chem Res Toxicol; 2005 Jan; 18(1):61-9. PubMed ID: 15651850
[TBL] [Abstract][Full Text] [Related]
47. [Determination of volatile nitrosamines in urine through gas chromatography-mass spectrometry].
Guo RZ; Wan YJ; Wu CJ; Zhang Y; Huang QH; Li HX; Wang X; Cao ZH; Mao YH; Shen J; Xia W; Li YY; Xu SQ
Zhonghua Yu Fang Yi Xue Za Zhi; 2013 Mar; 47(3):270-3. PubMed ID: 23866756
[TBL] [Abstract][Full Text] [Related]
48. [Urban air pollution by carcinogenic N-nitrosamines].
Khesina AIa; Krivosheeva LV; Sokol'skaia NN; Koliadich MN
Vestn Ross Akad Med Nauk; 1996; (3):25-8. PubMed ID: 8672956
[TBL] [Abstract][Full Text] [Related]
49. Application of a framework for the selection of an appropriate occupational exposure limit for manganese.
Deveau M; Maier A; Krewski D
Neurotoxicology; 2017 Jan; 58():249-256. PubMed ID: 27663849
[TBL] [Abstract][Full Text] [Related]
50. Estimated Cancer Risks Associated with Nitrosamine Contamination in Commonly Used Medications.
Li K; Ricker K; Tsai FC; Hsieh CJ; Osborne G; Sun M; Marder ME; Elmore S; Schmitz R; Sandy MS
Int J Environ Res Public Health; 2021 Sep; 18(18):. PubMed ID: 34574388
[TBL] [Abstract][Full Text] [Related]
51. Derivation of occupational exposure limits: Differences in methods and protection levels.
Schneider K; Dilger M; Drossard C; Ott H; Kaiser E
J Appl Toxicol; 2022 May; 42(5):913-926. PubMed ID: 35188277
[TBL] [Abstract][Full Text] [Related]
52. Genotoxicity evaluation of nitrosamine impurities using human TK6 cells transduced with cytochrome P450s.
Li X; He X; Le Y; Guo X; Bryant MS; Atrakchi AH; McGovern TJ; Davis-Bruno KL; Keire DA; Heflich RH; Mei N
Arch Toxicol; 2022 Nov; 96(11):3077-3089. PubMed ID: 35882637
[TBL] [Abstract][Full Text] [Related]
53. Comparative study on the carcinogenicity of N-nitrosodiethylamine, N-nitrosodimethylamine, N-nitrosomorpholine, N-nitrosopyrrolidine and N-nitrosodi-n-propylamine to the lung of Syrian golden hamsters following intermittent instillations to the trachea.
Ishinishi N; Tanaka A; Hisanaga A; Inamasu T; Hirata M
Carcinogenesis; 1988 Jun; 9(6):947-50. PubMed ID: 3370758
[TBL] [Abstract][Full Text] [Related]
54. An interdisciplinary framework for derivation of occupational exposure limits.
Maurer LL; Alexander MS; Bachman AN; Grimm FA; Lewis RJ; North CM; Wojcik NC; Goyak KO
Front Public Health; 2022; 10():1038305. PubMed ID: 36530659
[TBL] [Abstract][Full Text] [Related]
55. Biotransformation of nitrosamines and precursor secondary amines under methanogenic conditions.
Tezel U; Padhye LP; Huang CH; Pavlostathis SG
Environ Sci Technol; 2011 Oct; 45(19):8290-7. PubMed ID: 21863807
[TBL] [Abstract][Full Text] [Related]
56. Occurrence of N-nitrosamines in U.S. freshwater sediments near wastewater treatment plants.
Gushgari AJ; Halden RU; Venkatesan AK
J Hazard Mater; 2017 Feb; 323(Pt A):109-115. PubMed ID: 27067539
[TBL] [Abstract][Full Text] [Related]
57. Genotoxicity assessment of eight nitrosamines using 2D and 3D HepaRG cell models.
Seo JE; Yu JZ; Xu H; Li X; Atrakchi AH; McGovern TJ; Bruno KLD; Mei N; Heflich RH; Guo X
Arch Toxicol; 2023 Oct; 97(10):2785-2798. PubMed ID: 37486449
[TBL] [Abstract][Full Text] [Related]
58. Nitrosamines in pilot-scale and full-scale wastewater treatment plants with ozonation.
Gerrity D; Pisarenko AN; Marti E; Trenholm RA; Gerringer F; Reungoat J; Dickenson E
Water Res; 2015 Apr; 72():251-61. PubMed ID: 25037928
[TBL] [Abstract][Full Text] [Related]
59. Occurrence and transport of N-nitrosamines in the urban water systems of the Pearl River Delta, southern China.
Chen W; Li S; Huang H; Chen Y; Chen W; Ding Y; Yan X; Liang Y; Cen K; Qi S
Sci Total Environ; 2023 Sep; 890():164251. PubMed ID: 37201810
[TBL] [Abstract][Full Text] [Related]
60. Use of differential DNA-repair host mediated assays to investigate the biotransformation of xenobiotics in Drosophila melanogaster. I. Genotoxic effects of nitrosamines.
Knasmuller S; Szakmary A; Kehrer M
Chem Biol Interact; 1990; 75(1):17-29. PubMed ID: 2114223
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
